The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124920463 12492046 3 F 20130117 20160907 20160623 20160915 EXP JP-JNJFOC-20150719696 JANSSEN 37.31 YR A M Y 0.00000 20160915 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124920463 12492046 1 SS PREZISTA DARUNAVIR ETHANOLATE 1 Oral Y N 0 800 MG TABLETS QD
124920463 12492046 2 PS PREZISTA DARUNAVIR ETHANOLATE 1 Oral Y N 21976 1200 MG TABLETS QD
124920463 12492046 3 SS DOXIL DOXORUBICIN HYDROCHLORIDE 1 Intravenous (not otherwise specified) 2 COURSE Y N 0 20 MG/M**2 LIPOSOME INJECTION
124920463 12492046 4 SS DOXIL DOXORUBICIN HYDROCHLORIDE 1 Intravenous (not otherwise specified) 1 COURSE Y N 50718 20 MG/M**2 LIPOSOME INJECTION
124920463 12492046 5 SS NORVIR RITONAVIR 1 Oral U 0 200 MG UNSPECIFIED QD
124920463 12492046 6 SS NORVIR RITONAVIR 1 Oral U 0 100 MG UNSPECIFIED QD
124920463 12492046 7 SS EPIVIR LAMIVUDINE 1 Oral U 0 300 MG UNSPECIFIED QD
124920463 12492046 8 SS EPZICOM ABACAVIR SULFATELAMIVUDINE 1 Oral U 0 1 DF TABLET QD
124920463 12492046 9 C EDURANT RILPIVIRINE HYDROCHLORIDE 1 Oral 0 25 MG TABLETS QD
124920463 12492046 10 C CRAVIT LEVOFLOXACIN 1 Oral 0 500 MG UNSPECIFIED QD
124920463 12492046 11 C GANCICLOVIR. GANCICLOVIR 1 Intravenous (not otherwise specified) 0 600 MG INJECTION QD
124920463 12492046 12 C ETHAMBUTOL HYDROCHLORIDE. ETHAMBUTOL HYDROCHLORIDE 1 Oral 0 750 MG UNSPECIFIED QD
124920463 12492046 13 C CLARITHROMYCIN. CLARITHROMYCIN 1 Oral 0 400 MG UNSPECIFIED QD
124920463 12492046 14 C MYCOBUTIN RIFABUTIN 1 Oral 0 300 MG UNSPECIFIED QD
124920463 12492046 15 C MYCOBUTIN RIFABUTIN 1 Oral 0 150 MG UNSPECIFIED QD
124920463 12492046 16 C ZITHROMAC AZITHROMYCIN DIHYDRATE 1 Oral 0 1200 MG UNSPECIFIED /wk
124920463 12492046 17 C SAMTIREL ATOVAQUONE 1 Oral 0 750 MG UNSPECIFIED QD
124920463 12492046 18 C VANCOMYCIN HYDROCHLORIDE. VANCOMYCIN HYDROCHLORIDE 1 Intravenous (not otherwise specified) 0 2 G INJECTION QD
124920463 12492046 19 C GRAN FILGRASTIM 1 Subcutaneous 0 75 UG INJECTION QD
124920463 12492046 20 C CALONAL ACETAMINOPHEN 1 Oral 0 200 MG UNSPECIFIED QD
124920463 12492046 21 C ZIAGEN ABACAVIR SULFATE 1 Oral 0 600 MG UNSPECIFIED QD
124920463 12492046 22 C NEUTROGIN LENOGRASTIM 1 Unknown 0 250 UG INJECTION QD
124920463 12492046 23 C NEUTROGIN LENOGRASTIM 1 Unknown 0 100 UG INJECTION QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124920463 12492046 1 HIV infection
124920463 12492046 2 HIV infection
124920463 12492046 3 Kaposi's sarcoma AIDS related
124920463 12492046 4 Kaposi's sarcoma AIDS related
124920463 12492046 5 HIV infection
124920463 12492046 6 HIV infection
124920463 12492046 7 HIV infection
124920463 12492046 8 HIV infection
124920463 12492046 9 HIV infection
124920463 12492046 11 Cytomegalovirus chorioretinitis
124920463 12492046 12 Atypical mycobacterial infection
124920463 12492046 13 Atypical mycobacterial infection
124920463 12492046 14 Atypical mycobacterial infection
124920463 12492046 15 Atypical mycobacterial infection
124920463 12492046 16 Prophylaxis
124920463 12492046 17 Prophylaxis
124920463 12492046 18 Pyrexia
124920463 12492046 20 Pyrexia
124920463 12492046 21 HIV infection

Outcome of event

Event ID CASEID OUTC COD
124920463 12492046 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
124920463 12492046 Cytomegalovirus chorioretinitis
124920463 12492046 Nausea
124920463 12492046 Platelet count decreased
124920463 12492046 Renal impairment
124920463 12492046 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124920463 12492046 1 20130327 20130417 0
124920463 12492046 2 20130115 20130326 0
124920463 12492046 3 20130221 20130221 0
124920463 12492046 4 20130111 20130111 0
124920463 12492046 5 20130115 20130326 0
124920463 12492046 6 20130327 20130417 0
124920463 12492046 7 20130115 20130326 0
124920463 12492046 8 20130327 0
124920463 12492046 9 20130418 0
124920463 12492046 10 20130312 0
124920463 12492046 11 20130403 20130423 0
124920463 12492046 12 20130110 20130118 0
124920463 12492046 13 20130110 20130121 0
124920463 12492046 14 20130110 20130118 0
124920463 12492046 15 20130312 0
124920463 12492046 16 20130202 20130217 0
124920463 12492046 17 20130227 0
124920463 12492046 18 20130220 20130222 0
124920463 12492046 19 20130120 0
124920463 12492046 21 20130115 20130326 0
124920463 12492046 22 20130122 20130123 0
124920463 12492046 23 20130121 20130121 0

Execution Time: 0.0069818496704102 seconds (ucode:5212995). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.